AltaThera Pharmaceuticals Competitors and Similar CompaniesClear all

AltaThera Pharmaceuticals's competitors and similar companies include Alexion Pharmaceuticals, MediWound and Juvenescence.

	AltaThera Pharmaceuticals AltaThera Pharmaceuticals is a hospital-focused pharmaceutical company.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.	MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.	Juvenescence Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
Founding Date	Founding Date 2009	Founding Date 1992	Founding Date 2001	Founding Date 2016
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Chicago, US HQ	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more	Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US	Locations Dublin, IE HQ
Employees	Employees 462% increase	Employees 10,6006% increase	Employees 111	Employees 3310% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 40.3 b	Valuation ($) 196.3 m	Valuation ($) 500 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $6.1b (FY, 2020)	Revenue (est.) $17m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $553.5m (FY, 2020)	Cost of goods $13.1m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $5.5b (FY, 2020)	Gross profit $4.1m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income $603.4m (FY, 2020)	Net income ($23.9m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 1m (almost 11 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 100m (almost 7 years ago)